1. Home
  2. AZTR vs RAYA Comparison

AZTR vs RAYA Comparison

Compare AZTR & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • RAYA
  • Stock Information
  • Founded
  • AZTR 2014
  • RAYA 2019
  • Country
  • AZTR United States
  • RAYA China
  • Employees
  • AZTR N/A
  • RAYA N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • AZTR Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • AZTR Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • AZTR 4.2M
  • RAYA 4.3M
  • IPO Year
  • AZTR 2023
  • RAYA 2022
  • Fundamental
  • Price
  • AZTR $0.34
  • RAYA $3.87
  • Analyst Decision
  • AZTR Strong Buy
  • RAYA
  • Analyst Count
  • AZTR 1
  • RAYA 0
  • Target Price
  • AZTR $4.00
  • RAYA N/A
  • AVG Volume (30 Days)
  • AZTR 2.8M
  • RAYA 29.5K
  • Earning Date
  • AZTR 11-12-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • AZTR N/A
  • RAYA N/A
  • EPS Growth
  • AZTR N/A
  • RAYA N/A
  • EPS
  • AZTR N/A
  • RAYA N/A
  • Revenue
  • AZTR N/A
  • RAYA $30,300,360.00
  • Revenue This Year
  • AZTR N/A
  • RAYA $20.95
  • Revenue Next Year
  • AZTR N/A
  • RAYA N/A
  • P/E Ratio
  • AZTR N/A
  • RAYA N/A
  • Revenue Growth
  • AZTR N/A
  • RAYA 49.10
  • 52 Week Low
  • AZTR $0.32
  • RAYA $3.49
  • 52 Week High
  • AZTR $4.33
  • RAYA $736.99
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 29.98
  • RAYA 44.02
  • Support Level
  • AZTR $0.32
  • RAYA $3.71
  • Resistance Level
  • AZTR $0.43
  • RAYA $4.16
  • Average True Range (ATR)
  • AZTR 0.07
  • RAYA 0.30
  • MACD
  • AZTR -0.01
  • RAYA -0.11
  • Stochastic Oscillator
  • AZTR 3.02
  • RAYA 19.21

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: